Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorNombre químico: N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-glutamic-acid-gamma-[N-{1-(4,4-dimethyl-2,6-dixocyclohexylidene-3-methylbutyl}amino]benzyl ester // Sinónimos: 5-[[4-[[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino]phenyl]methyl] hydrogen N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-glutamate,(2S)-5-[[4-[[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)- 3-methylbutyl]amino]phenyl]methoxy]-2-(9H-fluoren-
from 240,00 €
The 4-{N-[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino}benzyl (Dmab) protecting group is compatible with the Fmoc/tert-butyl strategy used in standard peptide chemistry and is not cleaved during the final TFA treatment. Dmab esters are easily removed on solid phase or in solution using 2% hydrazine.
References:
A new photolabile carboxyl protecting group for native chemical ligation; B. Briand, N. Kotzur, V. Hagen, M. Beyermann; Tetrahedron Lett. 2008; 49(1): 85-87. https://doi.org/10.1016/j.tetlet.2007.11.028.
Development of Conformationally Constrained a-RgIAAnalogues as Stable Peptide Antagonists of Human a9a10Nicotinic Acetylcholine Receptors; N. Zheng, S. B. Christensen, A. Blakely, C. Dowel, L. Purushottam, J. M. McIntosh, D. H.-C. Chou; J. Med. Chem. 2020; 63(15): 8380-8387. https://doi.org/10.1021/acs.jmedchem.0c00613.
Secondary structural preferences of some antibacterial cyclooctapeptides in the presence of calcium(II); T. Stevens, N. McNeil, X. Lin, M. Ngu-Schwemlein; Int. J. Med. Chem. 2012. https://doi.org/10.1155/2012/730239.
Por favor envíeme más información sobre